This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Huiquan Duan: Innovator in Medical Technology
Introduction
Huiquan Duan is a notable inventor based in Tianjin, China. He has made significant contributions to the field of medical technology, particularly in the area of nerve injury repair. His innovative work has the potential to improve the quality of life for individuals suffering from nerve-related ailments.
Latest Patents
Huiquan Duan holds a patent for the "Use of a compound in repairing nerve injury." This invention focuses on a specific compound, as shown in formula (I), which is utilized in the preparation of pharmaceutical compositions aimed at preventing and treating nerve injuries. The compound has been shown to reduce pro-inflammatory cytokine production, decrease apoptosis levels, promote neuron survival, and inhibit glial scar formation. These effects contribute significantly to the recovery of motor function after nerve injuries.
Career Highlights
Throughout his career, Huiquan Duan has demonstrated a commitment to advancing medical technology. His research and inventions have garnered attention for their practical applications in healthcare. His work is particularly relevant in the context of developing effective treatments for nerve injuries, which can have debilitating effects on patients.
Collaborations
Huiquan Duan has collaborated with notable colleagues, including Baoyou Fan and Chenxi Zhao. These partnerships have likely contributed to the depth and breadth of his research, enhancing the impact of his inventions in the medical field.
Conclusion
Huiquan Duan's contributions to medical technology, particularly in nerve injury repair, highlight his role as an innovative inventor. His patent reflects a significant advancement in the treatment of nerve injuries, showcasing the potential for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile